Boutorin A S, Gus'kova L V, Ivanova E M, Kobetz N D, Zarytova V F, Ryte A S, Yurchenko L V, Vlassov V V
Institute of Bioorganic Chemistry, Siberian Division of the USSR Academy of Sciences, Novosibirsk.
FEBS Lett. 1989 Aug 28;254(1-2):129-32. doi: 10.1016/0014-5793(89)81023-3.
5'-[32P]-labelled alkylating decathymidylate [4-(N-2-chloroethyl)N-methylaminobenzyl]-5'-phosphamide derivatives containing cholesterol or phenazinium residues at their 3'-termini were synthesized and used for alkylation of DNA within mammalian cells. The uptake of the cholesterol derivative by the cells and the extent of DNA alkylation are about two orders of magnitude higher than those of a similar alkylating derivative lacking the groups at the 3'-termini. The presence of the phenazinium residue at the 3'-terminus of the oligonucleotide reagent does not improve the reagent uptake by the cells but drastically increases the DNA modification efficiency.
合成了在其3'-末端含有胆固醇或吩嗪鎓残基的5'-[32P]标记的烷基化十胸苷酸[4-(N-2-氯乙基)N-甲基氨基苄基]-5'-磷酰胺衍生物,并将其用于哺乳动物细胞内DNA的烷基化。细胞对胆固醇衍生物的摄取以及DNA烷基化的程度比在3'-末端缺少这些基团的类似烷基化衍生物高约两个数量级。寡核苷酸试剂3'-末端存在吩嗪鎓残基并不会提高细胞对试剂的摄取,但会显著提高DNA修饰效率。